Direct Stimulation of Angiotensin II Type 2 Receptor Initiated After Stroke Ameliorates Ischemic Brain Damage-Reference-Cited by-同舟云学术

Direct Stimulation of Angiotensin II Type 2 Receptor Initiated After Stroke Ameliorates Ischemic Brain Damage

Published:2014-02-26 Issue:8 Volume:27 Page:1036-1044
ISSN:0895-7061
Container-title:American Journal of Hypertension
language:en
Short-container-title:

Author:

Min Li-Juan,Mogi Masaki,Tsukuda Kana,Jing Fei,Ohshima Kousei,Nakaoka Hirotomo,Kan-no Harumi,Wang Xiao-Li,Chisaka Toshiyuki,Bai Hui-Yu,Iwanami Jun,Horiuchi Masatsugu

Publisher

Oxford University Press (OUP)

Subject

Internal Medicine

Link

http://academic.oup.com/ajh/article-pdf/27/8/1036/17046453/hpu015.pdf

Reference34 articles.

1. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol;Lancet,2002

2. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES);Stroke,2005

3. Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage;Br J Pharmacol,2011

4. Treatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarction;J Hypertens,2010

5. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis;BMJ,2010

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stimulation of Angiotensin II Receptor Subtype 2 Reduces Preeclampsia-like Symptoms in a Mouse Model of Preeclampsia;Current Issues in Molecular Biology;2024-09-02

2. Effect of AT1 receptor blockade on cardiovascular outcome after cardiac arrest: an experimental study in rats;Scientific Reports;2023-10-25

3. Effect of AT1 receptor blockade on cardiovascular outcome after cardiorespiratory arrest: an experimental study in rats;2023-05-18

4. Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disorders;Journal of Neurochemistry;2023-03-27

5. The Angiotensin AT₂Receptor: From a Binding Site to a Novel Therapeutic Target;Pharmacological Reviews;2022-09-30